Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamish Innes

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Gut|March 29, 2020
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage studySharon J Hutchinson, Heather Valerio, Scott A McDonald, et al.
Drug and Alcohol Dependence|June 9, 2016
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsAmanda Weir, Allan McLeod, Hamish Innes, et al.
Gastroenterology|June 21, 2020
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1Hamish Innes, Stephan Buch, Sharon Hutchinson, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.
Gut|July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
Communications Biology|August 21, 2025
Publisher Correction: fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experienceMeryem A Yücel, Robert Luke, Rickson C Mesquita, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Gut|March 29, 2020
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage studySharon J Hutchinson, Heather Valerio, Scott A McDonald, et al.
Drug and Alcohol Dependence|June 9, 2016
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsAmanda Weir, Allan McLeod, Hamish Innes, et al.
Gastroenterology|June 21, 2020
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1Hamish Innes, Stephan Buch, Sharon Hutchinson, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.
Gut|July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
Communications Biology|August 21, 2025
Publisher Correction: fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experienceMeryem A Yücel, Robert Luke, Rickson C Mesquita, et al.
Pageof 11